|
Following the recommendations of the Peer Review Panel that were based on overall quality assessment of all eligible applications received in response to the 2nd Joint Transnational Call, the Call Steering Committee of EuroNanoMed selected the following projects for funding (alphabetic order):
|
|
ACRONYM |
FULL TITLE |
COORDINATOR |
COORDINATING COUNTRY |
|
BIBA |
Delivering nanopharmaceuticals through BIological Barriers |
Patrick Boisseau (CEA – Commissariat à l’énergie atomique) |
France |
|
HCVAX |
Development of a Hepatitis C vaccine by targeted delivery of nanogel RNA-replicon constructs |
Ken McCullough (Institute of Virology and Immunoprophylaxis) |
Switzerland |
|
iNanoDCs |
Design of multifunctional nanoparticles targeting TLR or Nod receptors for dendritic cell immune therapy |
Bernard Verrier (Centre National Recherche Scientifique) |
France |
|
NANOASIT |
Novel drug delivery routes mediated via nanotechnology; targeting allergy vaccination |
Håkan Engqvist (Uppsala University) |
Sweden |
|
NANODIATER |
Nanoparticles designed to target chemokine-related inflammatory processes in vascular diseases and cancer metastasis and implementation of a biosensor to diagnose these disorders |
Maya Simionescu (Institute of Cellular Biology and Pathology “ N. Simionescu”) |
Romania |
|
NanoGene |
Stem cell generation and manipulation by nanoparticle mediated gene transfer for the safe clinical application of gene-modified cells |
Christine Günther (Apceth GmbH & CoKG) |
Germany |
|
NanoSplice |
Nanoconstructs for delivery of RNA splice-switching oligonucleotide therapeutics |
Edvard Smith (Karolinska Institutet, Department of Laboratory Medicine) |
Sweden |
|
REBONE |
Hybrid Nanostructured Hydrogels: Bone regeneration using multifunctional injectable hydrogels |
José Domingos Silva Santos (Biosckin Molecular and Cell Therapies S.A.) |
Portugal |
|
The final budget of each funded project partner is to be negotiated and specified by the relevant funding agency.
|